PMID: 9545535Apr 18, 1998Paper

Regulation of pyruvate dehydrogenase activity and glucose metabolism in post-ischaemic myocardium

Biochimica Et Biophysica Acta
H SchöderD B Buxton

Abstract

Pyruvate dehydrogenase (PDH) is regulated both by covalent modification and through modulation of the active enzyme by metabolites. In the isolated heart, post-ischaemic inhibition of PDH, leading to uncoupling of glycolysis and glucose oxidation and a decrease in cardiac efficiency, has been described. In vivo, post-ischaemic reperfusion leads to metabolic abnormalities consistent with PDH inhibition, but the effects of ischaemia/reperfusion on PDH are not well characterized. We therefore investigated PDH regulation following transient ischaemia in vivo. In 33 open-chest dogs, the left anterior descending (LAD) was occluded for 20 min followed by 4 h reperfusion. In 17 dogs, dichloroacetate (DCA) was injected prior to reperfusion, while 16 dogs served as controls. In dogs without DCA, glucose oxidation and lactate uptake were lower in reperfused than in remote tissue, suggesting reduced flux through PDH. However, percent active and total PDH measured in myocardial biopsies were similar in both territories, excluding covalent enzyme modification or loss of functional enzyme. DCA activated PDH activity similarly in both regions and abolished differences in glucose oxidation and lactate uptake. Thus, decreased PDH flux in reperfu...Continue Reading

References

Apr 15, 1978·Archives of Biochemistry and Biophysics·M S OlsonM S Debuysere
Aug 1, 1979·The Biochemical Journal·A L KerbeyP H Sugden
Jul 1, 1977·Progress in Cardiovascular Diseases·M A HeymannA M Rudolph
Mar 1, 1992·The Journal of Clinical Investigation·R R Russell, H Taegtmeyer
Aug 1, 1991·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A A VlessisD Trunkey
Jun 26, 1991·Molecular and Cellular Biochemistry·B RenstromS H Nellis
Feb 1, 1990·Circulation Research·B RenstromA J Liedtke
Nov 1, 1989·Metabolism: Clinical and Experimental·P W Stacpoole
Mar 1, 1989·Journal of the American College of Cardiology·M SchwaigerM Phelps
Feb 1, 1985·The Journal of Clinical Investigation·J Weiss, B Hiltbrand
Nov 1, 1985·The Journal of Clinical Investigation·J A WisneskiJ C Craig
Feb 12, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·A NomaM Kita
Jun 1, 1983·Journal of Molecular and Cellular Cardiology·K Kobayashi, J R Neely
Apr 1, 1995·Circulation·E D Lewandowski, L T White
Jun 1, 1994·Free Radical Biology & Medicine·Y E BogaertG Fiskum
Jan 11, 1994·Biochimica Et Biophysica Acta·J Gamble, G D Lopaschuk
Jan 1, 1994·The American Journal of Physiology·D R JaneroH M Sharif
Jun 1, 1996·The Journal of Surgical Research·J A WahrS F Bolling
Feb 1, 1996·Journal of Molecular and Cellular Cardiology·B ClarkeJ G McCormack
May 1, 1996·Journal of Molecular and Cellular Cardiology·W C StanleyJ G McCormack
Dec 1, 1996·Cardiovascular Research·R J KnightD B Buxton

❮ Previous
Next ❯

Citations

Nov 25, 2004·Journal of Neuroscience Research·Erica MartinGary Fiskum
Mar 23, 2010·Pflügers Archiv : European journal of physiology·Vu Thi ThuJin Han
Feb 11, 2003·Analytical Biochemistry·Joseph P SterkJanos Kerner
May 30, 2001·Advanced Drug Delivery Reviews·D MorinJ Tillement
Feb 13, 2008·Cardiovascular Drugs and Therapy·C J Zuurbier, H B Van Wezel
Oct 29, 2008·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Matthew E MerrittCraig R Malloy
May 9, 2002·Expert Opinion on Investigational Drugs·William C Stanley
Oct 28, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Viktoria VereczkiGary Fiskum
Apr 2, 2003·Fundamental & Clinical Pharmacology·William C Stanley, Mario Marzilli
Aug 31, 2007·The Journal of Comparative Neurology·Daniel SunMichael Kalloniatis
Sep 21, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·William C Stanley
Jun 6, 2009·Chembiochem : a European Journal of Chemical Biology·Jens RipckeMarc Birringer
Mar 21, 2013·Stroke; a Journal of Cerebral Circulation·Xiaokun GengYuchuan Ding
Jul 14, 2006·Clinical Physiology and Functional Imaging·Vittorio MantovaniEva Berglin
Jan 24, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Chiara d'AgostinoFabio A Recchia
Jul 17, 2001·American Journal of Physiology. Heart and Circulatory Physiology·J TerrandR Lerch
Apr 12, 2001·American Journal of Physiology. Heart and Circulatory Physiology·J G Van EmousC J Van Echteld
Dec 12, 2001·American Journal of Physiology. Endocrinology and Metabolism·Fabio A RecchiaWilliam C Stanley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.